View in EDS

Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies.

Saved in:
Bibliographic Details
Title: Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies.
Authors: du Rand A; School of Biological Sciences, The University of Auckland, Auckland, New Zealand., Buttle B; School of Biological Sciences, The University of Auckland, Auckland, New Zealand., Sheppard H; School of Biological Sciences, The University of Auckland, Auckland, New Zealand. h.sheppard@auckland.ac.nz.
Source: Drugs [Drugs] 2026 Apr; Vol. 86 (4), pp. 465-483. Date of Electronic Publication: 2026 Feb 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41731282
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22du+Rand+A%22">du Rand A</searchLink>; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Buttle+B%22">Buttle B</searchLink>; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sheppard+H%22">Sheppard H</searchLink>; School of Biological Sciences, The University of Auckland, Auckland, New Zealand. h.sheppard@auckland.ac.nz.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227600076%22">Drugs</searchLink> [Drugs] 2026 Apr; Vol. 86 (4), pp. 465-483. <i>Date of Electronic Publication: </i>2026 Feb 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>7600076 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1950 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200126667%22">00126667 </searchLink><i>NLM ISO Abbreviation: </i>Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41731282
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40265-026-02285-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 465
    Titles:
      – TitleFull: Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: du Rand A
      – PersonEntity:
          Name:
            NameFull: Buttle B
      – PersonEntity:
          Name:
            NameFull: Sheppard H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1950
          Numbering:
            – Type: volume
              Value: 86
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Drugs
              Type: main
ResultId 1